Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Sunitinib malate (substance) |
Is a |
Sunitinib (substance) |
false |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Has disposition (attribute) |
Protein-tyrosine kinase inhibitor (disposition) |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is a |
Azole |
false |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is a |
Protein-tyrosine kinase inhibitor |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is modification of (attribute) |
Sunitinib (substance) |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is a |
Enzyme inhibitor |
false |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is a |
Pyrrole |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is a |
Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Has disposition (attribute) |
Angiogenesis inhibitor (disposition) |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Has disposition (attribute) |
Vascular endothelial growth factor receptor antagonist (disposition) |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is a |
Antineoplastic agent (substance) |
true |
Inferred relationship |
Some |
|
|
Sunitinib malate (substance) |
Is a |
Angiogenesis inhibitor |
true |
Inferred relationship |
Some |
|
|